Sertraline for the treatment of depression in Alzheimer’s disease: Week-24 outcomes

BACKGROUND: Depression and antidepressant use are common in Alzheimer’s disease (AD), but the effect of antidepressant treatment for depression on longer-term outcomes is unknown. We report the week-24 outcomes of patients who participated in a 12-week efficacy study of sertraline for depression of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Weintraub, Daniel, Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849739/
https://ncbi.nlm.nih.gov/pubmed/20220589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JGP.0b013e3181cc0333
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items